[Noticeable meta-analysis of atenolol does not cover all aspects].
Forsén
Kent
K
Medicinsk marknadskonsult, Mölndal. kent.forsen.mma@telia.com
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000517:prevention & control; D015201:Meta-Analysis as Topic; D011322:Primary Prevention
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001262:Atenolol